Evidence map›Paper›PMID 31762163›Full record

Observational studyInternational wound journal2020

Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers.

F Dámaso Fernández-Ginés, Manuel Cortiñas-Sáenz, Desirée Agudo-Ponce, Ana Navajas-Gómez de Aranda, José A Morales-Molina, Carmen Fernández-Sánchez, Francisco Sierra-García, Héctor Mateo-Carrasco

Open access · greenAbstract readComparative StudyObservational Study
In one paragraph

Observational study in International wound journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. A randomised, double-blind, placebo-controlled study to determine the analgesic efficacy, safety and tolerability of VPX638 administered topically to painful wounds.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Trial
  4. Peptide-Based Approaches for Pain Relief and Healing in Wounds.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

F Dámaso Fernández-GinésPharmacy Department, Torrecárdenas Hospital, Almería, Spain.ORCID https://orcid.org/0000-0002-9442-9806
Manuel Cortiñas-SáenzAnesthesiology and Pain Management Department, Torrecárdenas Hospital, Almería, Spain.
Desirée Agudo-PonceAnesthesiology and Pain Management Department, Torrecárdenas Hospital, Almería, Spain.
Ana Navajas-Gómez de ArandaAnesthesiology and Pain Management Department, Torrecárdenas Hospital, Almería, Spain.
José A Morales-MolinaPharmacy Department, Torrecárdenas Hospital, Almería, Spain.
Carmen Fernández-SánchezPharmacy Department, Torrecárdenas Hospital, Almería, Spain.
Francisco Sierra-GarcíaPharmacy Department, Torrecárdenas Hospital, Almería, Spain.
Héctor Mateo-CarrascoDepartment of Clinical Pharmacy, Division of Oncology, University College London Hospital, London, UK.
Complejo Hospitalario Torrecárdenas · ESUniversity College Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, it has been reported that topical irrigations of liquid sevoflurane on the bed of painful wounds produce a rapid, intense, and lasting analgesic effect. In this paper, A cohort of 112 patients with painful pressure ulcers who were refractory to opioids (or who exhibited undesirable adverse events to them) was treated with topical sevoflurane as per local institutional policy. These patients were recruited from an intensive care unit for a period of 3 years. The main aim was to determine the effectiveness of topical sevoflurane in reducing the pain of PUs and reducing the ulcer area. Study findings are reported and discussed herein and suggest that sevoflurane is a viable and promising treatment option for PUs.

Indexed as

Administration, IntravenousAdministration, TopicalAdultAgedAged, 80 and overAnalgesics, OpioidCohort StudiesFemaleHumansMaleMiddle AgedPainPlatelet Aggregation InhibitorsPressure UlcerProspective StudiesSevofluraneAnalgesics, OpioidPlatelet Aggregation InhibitorsSevofluraneopioidpainpressure ulcersevofluranetopical treatment

Identifiers

PMID31762163
PMCPMC7948686
OpenAlexW2990447910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.